Go Deep
Molbio Diagnostics Limited
Molbio Diagnostics Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,644 | 103.8 | 14.79 | 0.34 | 1,501.10 |
| Oct 2026 | 15,683 | 99.5 | 14.18 | 0.34 | 1,438.60 |
Molbio Diagnostics Limited Quarterly Results
| Line Item | Jun 2026 | Jun 2025 |
|---|---|---|
| Revenue | 4,083,760,000.0 | 997,080,000.0 |
| Net Profit | 587,470,000.0 | -237,140,000.0 |
| EPS | 5.1 | -2.1 |
Molbio Diagnostics Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 14,149,580,000.0 | 9,974,820,000.0 | 8,197,250,000.0 | 3,224,280,000.0 |
| Net Profit | 1,665,940,000.0 | 1,451,030,000.0 | 1,019,540,000.0 | -7,260,000.0 |
| EPS | 14.5 | 12.6 | 8.8 | -0.1 |
Molbio Diagnostics Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total Assets | 21,484,240,000.0 | 14,615,550,000.0 | 12,210,560,000.0 | 10,342,110,000.0 |
| Total Liabilities | 8,396,480,000.0 | 4,942,700,000.0 | 3,922,190,000.0 | 2,968,700,000.0 |
| Total Equity | 11,693,360,000.0 | 9,683,910,000.0 | 8,233,810,000.0 | 7,214,790,000.0 |
Owes vs Owns
Molbio Diagnostics Limited owed ₹0.39 for every ₹1 it owned in Mar 2026, up from ₹0.29 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.39× | 0.34× | 0.32× | 0.29× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Molbio Diagnostics Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 17.3%Receivables 19.0%Inventory 20.9%Fixed assets (tangible) 14.9%Intangible assets 10.8%Other assets 16.8%
How it's funded — Mar 2026
Short-term debt 9.3%Long-term debt 9.9%Payables 9.3%Other liabilities 10.6%Shareholders' equity 60.9%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 370.6 | 129.1 | 12.8 | 7.2 |
| Receivables | 408.7 | 271.7 | 425.4 | 188.8 |
| Inventory | 449.3 | 435.9 | 315.1 | 347.0 |
| Fixed assets (tangible) | 319.2 | 277.0 | 186.9 | 199.5 |
| Intangible assets | 232.9 | 56.6 | 74.3 | 95.1 |
| Long-term investments | 6.0 | 45.6 | 6.0 | 6.0 |
| Other assets | 361.7 | 245.7 | 200.5 | 190.6 |
| Liabilities & equity | ||||
| Short-term debt | 200.2 | 117.0 | 159.5 | 107.5 |
| Long-term debt | 212.4 | 6.1 | 15.1 | 1.0 |
| Payables | 199.5 | 230.2 | 94.0 | 85.5 |
| Other liabilities | 227.5 | 140.9 | 123.7 | 102.9 |
| Shareholders' equity | 1,308.8 | 967.3 | 828.8 | 737.3 |
| Net tangible assets | 936.4 | 911.8 | 749.1 | 626.4 |
Molbio Diagnostics Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating Activities | 503,850,000.0 | 2,871,030,000.0 | 95,700,000.0 | 641,320,000.0 |
| Investing Activities | -932,220,000.0 | -1,226,530,000.0 | -450,100,000.0 | -397,320,000.0 |
| Financing Activities | 2,760,660,000.0 | -261,470,000.0 | -315,530,000.0 | 182,430,000.0 |